Biovex International is one of The Leading Supplier of Sheep & Goat Vaccine
Goat and Sheep vaccines are used to prevent a variety of diseases that can affect these animals. These diseases can cause significant morbidity and mortality in goats and sheep, and can also result in reduced productivity and profitability for farmers and ranchers. By using vaccines, it is possible to protect goats and sheep against these diseases and maintain their health and productivity.
Sheep and Goat box disease is characterised by fever and papules and nodules are also seen also internal lesions are observed. This comes under highly fatal disease. Goat and sheep pox vaccine is a freeze-dried live attenuated Sheep and goat pox viral vaccine prepared from the sheep and goat pox strain of the capripox virus.
​
-
PRESENTATION: 1 ml, 5 ml & 10 ml vials.
-
Administered subcutaneously of 1ml per vial.
LIVE ATTENUATED CONTAGIOUS PUSTULAR DERMATITIS VIRUS VACCINE
This is a freeze-dried live attenuated Contagious Pustular Dermatitis viral vaccine Contagious Pustular Dermatitis (ORF) is a highly infectious viral disease caused in sheep and goats characterized by the appearance of lesions on the muzzle and lips. Causative organism for this disease is dermatotropic ungulate pox virus.
-
PRESENTATION: 100 Dose vials.
-
Administered by making 3 to 4 short superficial scratches with a sterile hypodermic needle.
PPR is a highly contagious disease commonly known as goat plague characterised by sudden onset of depression, fever, discharges from the eyes and nose, sores in the mouth, disturbed breathing and cough, foul-smelling diarrhoea and death. The virus is propagated in vero cells mixed with stabilizer and freeze dried.
-
Sungri strain produced by using vero cell line
-
Administered through subcutaneous route.
PRESENTATION: 20 and 100 Dose vials.
CLOSTRIDIUM PERFRINGES VACCINE, INACTIVATED I.P.
Clostridium is a Gram-positive, rod-shaped, anaerobic, spore-forming bacterium found in natural environments around the world. This vaccine contains toxoids and bacterins from Clostridium perfringens types B, C, and D, supplemented with aluminum hydroxide gel. Each dose contains at least 109 CFU of inactivated bacterins from Clostridium perfringens types B, C and D.
​
-
Administered through a subcutaneous route.
PRESENTATION: 50 doses in 100ml vials.